Copyright
©The Author(s) 2024.
World J Gastroenterol. Oct 14, 2024; 30(38): 4211-4220
Published online Oct 14, 2024. doi: 10.3748/wjg.v30.i38.4211
Published online Oct 14, 2024. doi: 10.3748/wjg.v30.i38.4211
Table 1 Clinical characteristics between two sub-groups of patients with gastric adenocarcinoma
| Clinical characteristics | HER-2 positive (n = 21) | HER-2 negative (n = 80) | P value |
| Age (years) | 59.33 ± 8.534 | 64.15 ± 10.152 | 0.049 |
| Sex | 0.221 | ||
| Male | 19 | 63 | |
| Female | 2 | 17 | |
| Specimen type | 0.007 | ||
| Gastrectomy | 14 | 72 | |
| Biopsy | 7 | 8 | |
| Tumor location | 0.676 | ||
| Cardia | 10 | 30 | |
| Body | 4 | 16 | |
| Antrum | 7 | 34 | |
| Differentiation degree | 0.001 | ||
| Poorly differentiated | 6 | 55 | |
| Non-poorly differentiated | 11 | 18 | |
| Lauren classification | 0.023 | ||
| Intestinal type | 8 | 22 | |
| Diffuse type | 0 | 25 | |
| Mixed type | 5 | 18 |
- Citation: Zhang WL, Sun J, Huang RF, Zeng Y, Chen S, Wang XP, Chen JH, Chen YB, Zhu CS, Ye ZS, Xiao YP. Whole-volume histogram analysis of spectral-computed tomography iodine maps characterizes HER2 expression in gastric cancer. World J Gastroenterol 2024; 30(38): 4211-4220
- URL: https://www.wjgnet.com/1007-9327/full/v30/i38/4211.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i38.4211